scholarly journals Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: The randomized, double-blind, phase ii/iii systemic lupus erythematosus evaluation of rituximab trial

2010 ◽  
Vol 62 (1) ◽  
pp. 222-233 ◽  
Author(s):  
Joan T. Merrill ◽  
C. Michael Neuwelt ◽  
Daniel J. Wallace ◽  
Joseph C. Shanahan ◽  
Kevin M. Latinis ◽  
...  
Keyword(s):  
Systemic Lupus Erythematosus ◽  
Phase Ii ◽  
Lupus Erythematosus ◽  
Active Systemic Lupus Erythematosus ◽  
Efficacy And Safety ◽  
Systemic Lupus ◽  
Double Blind

scholarly journals A phase II, randomized, double-blind, placebo-controlled, dose-ranging study of belimumab in patients with active systemic lupus erythematosus

2009 ◽  
Vol 61 (9) ◽  
pp. 1168-1178 ◽  
Author(s):  
Daniel J. Wallace ◽  
William Stohl ◽  
Richard A. Furie ◽  
Jeffrey R. Lisse ◽  
James D. McKay ◽  
...  
Keyword(s):  
Systemic Lupus Erythematosus ◽  
Phase Ii ◽  
Lupus Erythematosus ◽  
Active Systemic Lupus Erythematosus ◽  
Systemic Lupus ◽  
Double Blind ◽  
Double Blind Placebo ◽  
Dose Ranging
Sign in / Sign up

Export Citation Format

Share Document